Management tracks

Gene therapy company uniQure N.V. (NASDAQ:QURE) named Paul Firuta chief commercial officer. He was chief commercial officer at BioBlast Pharma Ltd. (NASDAQ:ORPN).

Metabolic company Orexigen Therapeutics Inc. (NASDAQ:OREX) named Brian Longstreet SVP of global market access and development. Longstreet was managing director of the Global Health Investment Fund at Merck & Co. Inc. (NYSE:MRK). ...